BUDA Juice (BUDA) risk factors, FY2025 10-K

Risks Related to our Business and Industry

1. 01We have a limited operating history in new and evolving markets, which may make it difficult to evaluate our current business and future prospects and increase the risk of your investment
2. 02Our historical financial and operating results may not be indicative of future performance, and we may not be able to achieve and sustain the historical level of our profitability
3. 03We operate in a highly competitive beverage industry and may not be able to maintain or grow our market share against larger and better-capitalized competitors
4. 04Our success depends on the continued strength of our brand and consumer perception of the quality, safety, freshness, and healthfulness of our products
5. 05Our future growth depends on the successful development and acceptance of new product and product innovation
6. 06We rely on a limited number of cold chain-dependent production and distribution facilities, and any disruption—due to mechanical failure, labor shortages, natural disasters, or other causes—could materially affect our operations
7. 07Moreover, our ability to scale relies on the successful commissioning and ramp-up of additional cold-crafting hubs. Delays in the development or regulatory approval of future plants, or failures to operate those plants at expected efficiency levels, could constrain our capacity and slow geographic expansion
8. 08Our business model depends on maintaining strict cold chain logistics from sourcing through delivery, which adds operational complexity, cost, and vulnerability to temperature excursions or logistical delays
9. 09We have depended on a single customer for a substantial portion of our net sales, and the loss of this customer or a reduction in their purchases would materially and adversely affect our business, results of operations, and financial condition
10. 10We depend on a limited number of suppliers for our products, and the loss of one or more of these suppliers could disrupt our operations, increase our costs, or otherwise adversely affect our business
11. 11We depend on the availability, cost, and quality of fresh citrus and other raw ingredients, and agricultural or climate-related disruptions could adversely affect our supply and margins
12. 12We face risks associated with managing short shelf-life products, which increases our exposure to inventory spoilage, write-downs, and stockouts
13. 13Changes in consumer preferences—particularly away from fresh juice, citrus beverages, or premium-priced fresh products—could adversely affect demand for our offerings
14. 14Our growth strategy depends on geographic expansion, which requires securing and equipping new facilities and may be costly and complex
15. 15Our growth depends on expanding distribution through new retail relationships and deeper penetration with existing accounts; failure to secure or maintain these relationships on favorable terms may limit our revenue potential
16. 16We depend heavily on third-party retailers and in some cases brokers, to market and sell our products; their shelf prioritization, execution, or financial health may directly impact our performance
17. 17In addition, many of our retail customers sell competing products, and they may prioritize their own private-label offerings or those of larger, more established brands. We must continuously demonstrate value and performance to maintain shelf presence and retailer commitment
18. 18Our high-tech driven, centralized production systems are core to our efficiency and quality standards; technical failures or cybersecurity incidents could disrupt operations or result in data loss
19. 19We rely on third-party logistics providers for delivery of our products to our product outlets; any breakdown or delay could damage product integrity and customer trust
20. 20Inflationary pressures, rising freight or packaging costs, tariffs, and supply chain disruptions could materially affect our cost structure and financial condition
21. 21We may face difficulties in forecasting demand accurately, which could lead to excess inventory, underproduction, missed revenue opportunities, or higher working capital needs
22. 22Additionally, inaccuracies in forecasting can lead to suboptimal purchasing decisions and inefficient utilization of raw materials, packaging, and production resources. This can tie up working capital and strain our ability to respond flexibly to market shifts
23. 23If we fail to effectively manage our growth, including geographic expansion and increased retail distribution, our operations and customer experience could suffer
24. 24We may be subject to legal challenges related to the accuracy of our health and wellness claims
25. 25Agencies such as the FDA, FTC, and various state attorneys general have increased enforcement actions in recent years, and private class action lawsuits over product labeling and advertising have become common in the industry
26. 26Our future success depends on our ability to attract, retain, and develop key employees and senior leadership
27. 27We may require additional capital to support our growth strategy or operations, and such financing may not be available on acceptable terms or at all, which could limit our ability to scale
28. 28Disruptions in the worldwide economy may adversely affect our business, financial condition, results of operations and cash flows
29. 29Climate change, or legal or market measures to address climate change, may negatively affect our business and operations
30. 30Fluctuations in business conditions may unexpectedly impact our reported results of operations and financial condition
31. 31Our insurance may not provide adequate levels of coverage against claims or otherwise protect us from all risks to which we are exposed, or we may be unable to find insurance with sufficient coverage at a reasonable cost
32. 32Members of our management team have limited experience in operating a public company, and regulatory compliance may divert their attention from the day-to-day management of our business
33. 33We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices

Risks Relating to Legal and Regulatory Requirements

1. 34Food safety and food-borne illness incidents or other safety concerns may materially adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings
2. 35Litigation or legal proceedings could expose us to significant liabilities and have a negative impact on our reputation or business
3. 36Legislative or regulatory changes that affect our products, including new taxes, could reduce demand for products or increase our costs
4. 37Failure to comply with requirements to design, implement and maintain effective internal controls could have a material adverse effect on our business and stock price

Risks Relating to Our Information Technology and Intellectual Property

1. 38We may be unable to adequately protect our intellectual property or may face claims that we infringe the intellectual property of others

Risks Relating to Ownership of Our Common Stock

1. 39There has been limited daily volume of trading in our common stock, which has limited the overall and perceived liquidity of our common stock on that market
2. 40You may experience dilution of your ownership interest because of the future issuance of additional shares of our common stock and our preferred stock
3. 41If and when a larger trading market for our common stock develops, the market price of our common stock is still likely to be highly volatile and subject to wide fluctuations, and you may be unable to resell your shares at or above the price at which you acquired them
4. 42We have never declared or paid any cash dividends or distributions on our common stock. We currently intend to retain our future earnings, if any, to support operations and to finance expansion, and therefore we do not anticipate paying any cash dividends on our common stock in the foreseeable future
5. 43If securities or industry analysts do not publish research or reports about us, our business or our market, or if they change their recommendations regarding our stock adversely, our stock price and trading volume could decline